Abstract
People's unhealthy lifestyles, especially the number of smoking and passive smoking populations, are increasing year by year and the population is aging. With the development and progress of lung cancer cell and molecular biology, the incidence rate and mortality rate of lung cancer are increasing year by year. The existing tumor biochemotherapy has rapidly developed from preliminary research and animal research to clinical research. The smart cancer Zhongning therapeutic device can induce necrosis and apoptosis of tumor cells. The effect of treating tumors is getting more and more attention. Therefore, this article focuses on the effect of the smart cancer Zhongning therapeutic device on the tumor red blood cells and tumor cell cycle of mice with solid liver cancer. The immunological effects of the drug were discussed. Forty mice were randomly divided into high-dose group, low-dose group, 5-FU group, and model group. The effects of different treatment stages on tumor red blood cell immune function and cell cycle were recorded and evaluated, and the survival rate by multiplying the positive limit method was calculated. The model group is controlled by the exact probability method, and the Pss18.0 system is used to test the hypothesis of survival rate comparison. The experimental results showed that the tumor inhibition rate in this group was 65.8%. Compared with the 5-FU group and model group, the dose group has shown an antitumor effect and had significantly improved the tumor-bearing body's antitumor red blood cell immune function and tumor cell cycle.
Highlights
People’s unhealthy lifestyles, especially the number of smoking and passive smoking populations, are increasing year by year and the population is aging
Forty mice were randomly divided into high-dose group, low-dose group, 5-FU group, and model group. e effects of different treatment stages on tumor red blood cell immune function and cell cycle were recorded and evaluated, and the survival rate by multiplying the positive limit method was calculated. e model group is controlled by the exact probability method, and the Pss18.0 system is used to test the hypothesis of survival rate comparison. e experimental results showed that the tumor inhibition rate in this group was 65.8%
Radiotherapy combined with chemotherapy (RCT) or radiotherapy combined with EGFR blockade is more effective than radiotherapy alone, it needs to be optimized
Summary
Liver cancer is a cancer originating from liver cells. It is a common cancer of the liver, which is caused by the mutation of liver cells in DNA. Primary liver cancer is a disease that occurs when healthy cells in the liver become abnormal in appearance and behavior. Cancer cells will destroy adjacent normal tissues and spread to other areas of the liver and organs outside the liver [8, 9]. Ere are many treatment options for liver cancer. E choice of treatment depends on the extent of cancer spread, the overall health of the liver, and the health level of the patient. CTscan and liver contrast MRI are the preferred imaging methods to detect the location and degree of blood supply of cancer. If any imaging research is inconclusive, alternative imaging or follow-up imaging research should be carried out
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
